|
Report ID
|
11234 |
|
Drug Identification Number
|
02212188 |
|
Brand name
|
IMITREX INJECTION 12MG/ML |
|
Common or Proper name
|
Sumatriptan succinate injection |
|
Company Name
|
GLAXOSMITHKLINE INC |
|
Market Status
|
MARKETED |
|
Active Ingredient(s)
|
SUMATRIPTAN |
|
Strength(s)
|
12MG |
|
Dosage form(s)
|
LIQUID |
|
Route of administration
|
SUBCUTANEOUS |
|
Packaging size
|
5x0.5mL |
|
ATC code
|
N02CC |
|
ATC description
|
ANTIMIGRAINE PREPARATIONS |
|
Reason for shortage
|
Shortage of an active ingredient. |
|
Anticipated start date
|
|
|
Actual start date
|
2017-06-26 |
|
Estimated end date
|
2018-06-29 |
|
Actual end date
|
2018-06-26 |
|
Shortage status
|
Resolved |
|
Updated date
|
2018-06-27 |
|
Company comments
|
Supply released July 2017 and August 2017 with limited quantity |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
1-800-387-7374 |
